Webinar: How to stand out in IBD.
Hear what HCPs working in IBD are saying in 2024 and how it will help you cut through the noise.
Availability: Free for Life Sciences Companies
The number of patients with Inflammatory Bowel Disease (IBD) increased by 48% between 1990 and 2019, and continues to rise through the consumption of ultra-processed foods.
This has led to 20 treatments being indicated for IBD in the past five years and a further 30 being in Phase 3 trials or awaiting approval.
Whilst healthcare professionals (HCPs) welcome the increased availability of treatments our research shows that they are finding it increasingly challenging to optimise outcomes for patients.
Sign up for our webinar to hear how HCPs in two countries with growing incidences of IBD are talking about treatments and describing their biggest challenges.
Discover four key takeaways from our research related to:
- How the market is developing.
- Shaping clinical guidelines.
- Successful engagement strategies.
- Attitudes around lifestyle interventions.
Register today
